A mother shares how a records mishap has led to a trip to the hospital for her daughter with Type 1 diabetes.
A certified diabetes educator discusses why diabetes ups the risk of periodontal disease.
A woman with Type 1 chronicles a difficult journey to use the medicine that keeps her both alive and unwell.
Abbott, the maker of the Libre, touts an analysis of user data of the glucose monitoring system.
The organization launches workshops both in the U.S. and abroad.
The pump, which is sold internationally, could fail to charge because of it.
A researcher on diabetes and exercise describes why exercise elevates risk of DKA for people with Type 1 diabetes.
A woman with Type 1 claims a doctor withheld a prescription even though she was running out of insulin.
A team of international researchers release new guidelines based on the accumulation of research on the subject.
One-third of people affected by Type 1 diabetes lack any means to test for DKA at home.
It’s alleged that price fixing to keep the price of insulin high may have obscured trouble with the company’s bottom line.
Kinked cannulas may cause interruptions in insulin delivery.
The ruling paves way for partial Medicare and Medicaid coverage for qualifying CGMs.
It was the second FDA approval for the OneTouch Vibe pump system in 2016 alone.
The two-part report profiles the death of Kevin Houdeshell from lack of insulin, and his family’s efforts to prevent similar deaths.
Don’t read this list if you’re feeling queasy. Take our word on this.
A woman diagnosed with Type 1 grows frustrated with the dearth of information on the condition.
How to make sure you and a new doctor are on the same page about how to treat your Type 1 diabetes.
Federal regulators declare the CGM just as good as fingersticks in making blood sugar management decisions.
A look back at the breakthroughs…and the debate over the name.